Compare ABSI & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABSI | ACDC |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 1.1B |
| IPO Year | 2021 | 2021 |
| Metric | ABSI | ACDC |
|---|---|---|
| Price | $8.65 | $5.48 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | ★ $6.96 | $5.50 |
| AVG Volume (30 Days) | ★ 2.7M | 1.4M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,534,000.00 | ★ $1,941,800,000.00 |
| Revenue This Year | $215.96 | N/A |
| Revenue Next Year | $319.10 | $11.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $3.08 |
| 52 Week High | $12.06 | $8.22 |
| Indicator | ABSI | ACDC |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 60.95 |
| Support Level | $8.55 | $5.50 |
| Resistance Level | $10.03 | $8.07 |
| Average True Range (ATR) | 0.55 | 0.35 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 23.35 | 90.59 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.